Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.01B | -1.00B | -981.73M | -1.01B | -233.03M |
| Total Depreciation and Amortization | 228.46M | 249.81M | 270.60M | 288.81M | 279.16M |
| Total Amortization of Deferred Charges | 144.05M | 133.04M | 121.42M | 108.24M | 97.23M |
| Total Other Non-Cash Items | 965.43M | 948.40M | 963.76M | 980.49M | 199.52M |
| Change in Net Operating Assets | -24.90M | -36.32M | -36.19M | -38.73M | 2.91M |
| Cash from Operations | 300.68M | 293.68M | 337.86M | 333.29M | 345.79M |
| Capital Expenditure | -12.37M | -10.79M | -6.06M | -10.26M | -10.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -64.61M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -134.83M | -113.26M | -124.85M | -127.16M | -135.99M |
| Cash from Investing | -211.81M | -124.05M | -130.91M | -137.41M | -146.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.61M | 8.49M | 7.54M | 10.50M | 9.75M |
| Repurchase of Common Stock | -176.00K | -176.00K | -176.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -106.00K | -2.00K | -2.89M | -1.65M | -500.00K |
| Cash from Financing | 7.33M | 8.31M | 4.48M | 8.85M | 9.25M |
| Foreign Exchange rate Adjustments | -804.00K | -3.29M | 1.91M | -1.03M | 554.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.40M | 174.65M | 213.34M | 203.69M | 209.36M |